Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 850 of 2051 entries
View as:

A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00475735 Org: User:
Start: 07/31/07 End: 04/30/08 Due: 04/30/09

Use of Sugammadex at the End of Case in Routine Anesthesia (MK-8616-023)

Phase: N/A Priority: Normal
NCT ID: NCT00298831 Org: User:
Start: 10/27/05 End: 05/22/06 Due: 05/22/07

A Comparison of Two Dose Levels of Indinavir Combined With Two Nucleoside Analogue Reverse Transcriptase Inhibitors (NRTIs) in HIV-Infected Patients

Phase: N/A Priority: Normal
NCT ID: NCT00002406 Org: User:
Start: - End: - Due: -

Study to Evaluate Frozen Versus Refrigerated MMRV (Combined Measles, Mumps, Rubella, and Varicella) Investigational Vaccine (V221-016)

Phase: N/A Priority: Normal
NCT ID: NCT00092430 Org: User:
Start: 09/26/02 End: 06/09/03 Due: 06/09/04

Study to Evaluate Effect of a Single Dose of Sotatercept (ACE-011) on Red Blood Cell Mass and Plasma Volume in Participants With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT01190644 Org: User:
Start: 06/01/10 End: 10/29/12 Due: 10/29/13

Phase 2a Respiratory Syncytial Virus (RSV) Human Challenge Study of Clesrovimab (MK-1654) in Healthy Participants (MK-1654-005)

Phase: N/A Priority: Normal
NCT ID: NCT04086472 Org: User:
Start: 10/28/19 End: 08/14/20 Due: 08/14/21

An Investigational Drug Study to Assess Weight Loss in Patients With Type 2 Diabetes Mellitus (0364-011)(TERMINATED)

Phase: N/A Priority: Normal
NCT ID: NCT00430742 Org: User:
Start: 11/30/06 End: 11/30/08 Due: 11/30/09

A Study to Evaluate Remicade (Infliximab) in Moderate-to-Severe Chronic Plaque Psoriasis in the Middle Eastern Population (Study P04528)

Phase: N/A Priority: Normal
NCT ID: NCT00687362 Org: User:
Start: 05/30/06 End: 11/11/08 Due: 11/11/09

Study to Evaluate the Safety of Pembrolizumab in Participants With Unresectable or Metastatic Melanoma or Non-small Cell Lung Cancer in India (MK-3475-593/KEYNOTE-593)

Phase: N/A Priority: Normal
NCT ID: NCT03715205 Org: User:
Start: 01/31/19 End: 08/21/24 Due: 08/21/25

Biomarkers of Intestinal Mucosal Healing in Crohn's Disease (P08143)

Phase: N/A Priority: Normal
NCT ID: NCT01349920 Org: User:
Start: 11/28/12 End: 09/28/15 Due: 09/28/16

A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00100048 Org: User:
Start: 01/31/05 End: 07/31/10 Due: 07/31/11

A Study to Evaluate Safety and Efficacy of Caelyx in Combination With Cyclophosphamide in the Treatment of Metastatic Breast Cancer (P02948)

Phase: N/A Priority: Normal
NCT ID: NCT00779129 Org: User:
Start: 03/31/03 End: 08/31/07 Due: 08/31/08

A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)

Phase: N/A Priority: Normal
NCT ID: NCT00818259 Org: User:
Start: 02/05/09 End: 01/20/14 Due: 01/20/15

Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115)

Phase: N/A Priority: Normal
NCT ID: NCT00686543 Org: User:
Start: 12/31/07 End: 04/30/09 Due: 04/30/10

A Phase III Study of a 2-dose Regimen of a Multivalent Human Papillomavirus (HPV) Vaccine (V503), Administered to 9 to 14 Year-olds and Compared to Young Women, 16 to 26 Years Old (V503-010)

Phase: N/A Priority: Normal
NCT ID: NCT01984697 Org: User:
Start: 12/12/13 End: 07/24/17 Due: 07/24/18

Early Airway Response to Allergen in Asthmatics (MK-0000-176)

Phase: N/A Priority: Normal
NCT ID: NCT01061333 Org: User:
Start: 06/30/10 End: 03/31/11 Due: 03/31/12

A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4)

Phase: N/A Priority: Normal
NCT ID: NCT00959699 Org: User:
Start: 11/30/09 End: 10/31/12 Due: 10/31/13

Palonosetron in Moderately and Highly Emetogenic Chemotherapy Induced Nausea and Vomiting (Study P04935)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00684463 Org: User:
Start: 04/11/07 End: 02/22/08 Due: 02/22/09

A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218)

Phase: N/A Priority: Normal
NCT ID: NCT01866306 Org: User:
Start: 10/22/13 End: 01/18/16 Due: 01/18/17

Peg-Intron and Rebetol Therapy in Treatment of Naive Hepatitis C Patients: A Comparison of Race and Genotype on Treatment Outcome (Study P04212)

Phase: N/A Priority: Normal
NCT ID: NCT00255008 Org: User:
Start: 03/31/05 End: 12/31/07 Due: 12/31/08

Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031)

Phase: N/A Priority: Normal
NCT ID: NCT01594749 Org: User:
Start: 09/24/12 End: 11/03/14 Due: 11/03/15

Comparison of SCH 486757 to Codeine and Placebo in Subjects With Persistent Postviral Cough (Study P03069AM2)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00230230 Org: User:
Start: 10/31/05 End: 04/30/07 Due: 04/30/08

Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)

Phase: N/A Priority: Normal
NCT ID: NCT00975130 Org: User:
Start: 09/30/09 End: 02/29/12 Due: 02/28/13

A Study of MK0731 in Patients With Advanced Solid Tumors (0731-002)(COMPLETED)

Phase: N/A Priority: Normal
NCT ID: NCT00104364 Org: User:
Start: 05/31/05 End: 01/31/08 Due: 01/31/09

Observational Study of Patients With Chronic Hepatitis C Virus (HCV) Infected With HCV Genotype 1 Low Virus Load (LVL 1) and Effect of PegIntron Plus Rebetol Treatment (Study P04793 Part 2)

Phase: N/A Priority: Normal
NCT ID: NCT01054742 Org: User:
Start: 12/31/09 End: 06/30/11 Due: 06/30/12